Nyhetsflöde
@OrexoABpubl
12 april 2021
THIS IS BEYOND. Such an inspiring and hopeful story our colleague PSyD Gery-Lynn Utter brings to her important work… https://t.co/LqjD2va8er
@OrexoABpubl
8 april 2021
To avoid being captured in the vicious circle of #addiction there is a need of counselling support to cope with AUD… https://t.co/wcpUZLvlap
@OrexoABpubl
7 april 2021
Ethypharm acquires the rights to deprexis & vorvida in 4 European countries from our partner @GAIA_COM. Yet another… https://t.co/USDN34EMMN
Europa |
USA |
 |
|
|
Lena Wange IR & Corporate Communications Director Växel: +46 (0)18 780 88 00 Direktnummer: +48 73 064 16 36 Email: ir@orexo.com Plats: Uppsala, Sverige |
Dennis Urbaniak EVP Digital Therapeutics Växel: +1 (0)855 982 7658 Direktnummer: +1 973 294 3183 Email: us.media@orexo.com Plats: New Jersey, USA |
